News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
REED VICKIE S
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/11/2023 |
4
| REED VICKIE S (Director) has filed a Form 4 on Evoke Pharma Inc|
Txns:
| Granted 15,000 options to buy
@ $2.12, valued at
$31.8k
|
|
| 05/26/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/28/2022 |
4
| REED VICKIE S (Director) has filed a Form 4 on Evoke Pharma Inc|
Txns:
| Granted 58,000 options to buy
@ $0.66, valued at
$38.3k
|
|
| 01/18/2022 |
4
| REED VICKIE S (SVP, Chief Accounting Officer) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Granted 5,377 shares
@ $0
Sold 533 shares
@ $120.4826, valued at
$64.2k
Granted 8,910 options to buy
@ $124.31, valued at
$1.1M
|
|
| 01/07/2022 |
4
| REED VICKIE S (SVP, Chief Accounting Officer) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Sold 345 shares
@ $135.9419, valued at
$46.9k
|
|
| 01/06/2022 |
4
| REED VICKIE S (SVP, Chief Accounting Officer) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Sold 758 shares
@ $147.7395, valued at
$112k
|
|
| 05/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/17/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 01/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/12/2020 |
4/A
| REED VICKIE S (SVP, Chief Accounting Officer) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Granted 2,522 options to buy
@ $216.11, valued at
$545k
|
|
| 11/06/2020 |
4
| REED VICKIE S (SVP, Chief Accounting Officer) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Granted 2,523 options to buy
@ $216.11, valued at
$545.2k
|
|
| 01/15/2020 |
4
| REED VICKIE S (SVP, Chief Accounting Officer) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Granted 2,750 shares
@ $0
Granted 5,500 options to buy
@ $114.33, valued at
$628.8k
|
|
| 01/15/2020 |
3
| REED VICKIE S (SVP, Chief Accounting Officer) has filed a Form 3 on Mirati Therapeutics, Inc. |
|
|